Table 2. Association of Marital Status With CSS, Advanced-Stage Diagnosis, and Treatment by Cancer Site and Sex.
Cancer and sex | CSS | Diagnosed at an advanced stage | Receiving surgery | Receiving chemotherapy | Receiving RT | |||||
---|---|---|---|---|---|---|---|---|---|---|
TR for marriage (95% CI)a | P value | OR for marriage (95% CI)b | P value | OR for marriage (95% CI)c | P value | OR for marriage (95% CI)d | P value | OR for marriage (95% CI)e | P value | |
Lung | ||||||||||
Male | 1.12 (1.11-1.14) | <.001 | 1.00 (0.98-1.03) | .83 | 1.53 (1.47-1.59) | <.001 | 1.06 (1.04-1.09) | <.001 | 1.57 (1.53-1.61) | <.001 |
Female | 1.08 (1.06-1.10) | <.001 | 1.02 (1.00-1.05) | .10 | 1.33 (1.28-1.38) | <.001 | 1.05 (1.02-1.08) | <.001 | 1.32 (1.28-1.35) | <.001 |
Colorectum | ||||||||||
Male | 1.28 (1.25-1.32) | <.001 | 0.91 (0.80-0.94) | <.001 | 1.52 (1.46-1.58) | <.001 | 0.89 (0.86-0.92) | <.001 | 1.34 (1.30-1.38) | <.001 |
Female | 1.22 (1.19-1.26) | <.001 | 0.91 (0.89-0.94) | <.001 | 1.20 (1.15-1.25) | <.001 | 0.93 (0.89-0.97) | <.001 | 1.31 (1.26-1.35) | <.001 |
Pancreas | ||||||||||
Male | 1.16 (1.12-1.19) | <.001 | 1.01 (0.95-1.07) | .77 | 1.34 (1.22-1.47) | <.001 | 1.06 (0.99-1.15) | .10 | 1.63 (1.54-1.72) | <.001 |
Female | 1.08 (1.05-1.11) | <.001 | 1.06 (1.00-1.11) | .05 | 1.24 (1.14-1.35) | <.001 | 0.99 (0.92-1.06) | .71 | 1.50 (1.42-1.59) | <.001 |
Bladder | ||||||||||
Male | 1.50 (1.43-1.57) | <.001 | 0.81 (0.77-0.85) | <.001 | 1.25 (1.12-1.39) | <.001 | 0.76 (0.70-0.82) | <.001 | 1.17 (1.12-1.23) | <.001 |
Female | 1.40 (1.28-1.53) | <.001 | 0.96 (0.88-1.04) | .31 | 1.14 (0.95-1.37) | .15 | 0.78 (0.68-0.88) | <.001 | 1.25 (1.15-1.36) | <.001 |
Kidney | ||||||||||
Male | 1.18 (1.12-1.23) | <.001 | 0.91 (0.88-0.95) | <.001 | 1.76 (1.63-1.91) | <.001 | 1.03 (0.94-1.14) | .49 | 1.29 (1.20-1.38) | <.001 |
Female | 1.09 (1.02-1.16) | .009 | 0.97 (0.92-1.03) | .29 | 1.31 (1.18-1.45) | <.001 | 0.95 (0.84-1.08) | .45 | 1.17 (1.06-1.29) | .001 |
Melanoma | ||||||||||
Male | 1.42 (1.34-1.50) | <.001 | 0.71 (0.67-0.74) | <.001 | 1.08 (0.99-1.19) | .10 | 0.94 (0.85-1.05) | .29 | 1.03 (0.92-1.15) | .66 |
Female | 1.35 (1.24-1.47) | <.001 | 0.79 (0.74-0.84) | <.001 | 0.97 (0.86-1.09) | .61 | 0.91 (0.77-1.06) | .21 | 1.13 (0.96-1.32) | .14 |
Breast | ||||||||||
Male | 1.76 (1.19-2.61) | .005 | 0.83 (0.69-0.99) | .04 | 1.05 (0.53-2.03) | .90 | 1.00 (0.73-1.37) | >.99 | 1.09 (0.79-1.50) | .59 |
Female | 1.10 (1.07-1.14) | <.001 | 0.80 (0.78-0.81) | <.001 | 1.33 (1.26-1.39) | <.001 | 1.100 (1.07-1.13) | <.001 | 1.05 (1.03-1.07) | <.001 |
Total sample | ||||||||||
Male | 1.27 (1.25-1.28) | <.001 | 0.85 (0.84-0.86) | <.001 | 1.43 (1.40-1.46) | <.001 | 1.33 (1.31-1.35) | <.001 | 0.91 (0.90-0.93) | <.001 |
Female | 1.20 (1.19-1.21) | <.001 | 0.83 (0.82-0.84) | <.001 | 1.31 (1.29-1.33) | <.001 | 1.23 (1.22-1.25) | <.001 | 1.16 (1.14-1.17) | <.001 |
Abbreviations: CSS, cancer-specific survival; OR, odds ratio; RT, radiation therapy; TR, time ratio.
Adjusted for patient demographic characteristics (age, race, sex, insurance status, residence, poverty level, and educational level), stage, grade, receiving surgery, receiving chemotherapy, and receiving RT.
Adjusted for patient demographic characteristics and grade.
Adjusted for patient demographic characteristics, stage, grade, receiving chemotherapy, and receiving RT.
Adjusted for patient demographic characteristics, stage, grade, receiving surgery, and receiving RT.
Adjusted for patient demographic characteristics, stage, grade, receiving chemotherapy, and receiving surgery.